[1]
Karthickeyan, K., Saara, A., Gopal, K., Karthick, S. and Ashi, A. 2023. A REVIEW ON GLIMEPIRIDE VS TENELIGLIPTIN AS A SECOND-LINE DRUG FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS. JOURNAL OF EDUCATION AND SCIENTIFIC MEDICINE. 2, 3 (Sep. 2023), 73-79.